The proliferation of single-use systems (SUS) in the manufacture of pharmaceuticals and biopharmaceuticals has lowered costs and increased efficiency. Single-use systems, comprised of polymeric materials, offer many advantages over glass and stainless steel. However, selection and qualification of the most appropriate material and vendor can be challenging.
One challenge is that polymeric materials present a leachables risk. A second is that regulatory guidance does not include prescriptive procedures that can be followed in an extractable and leachable study. It is important to find a partner that can successfully navigate both material selection and qualification for SUS materials.